Loading provider…
Loading provider…
Hematology & Oncology Physician in Hattiesburg, MS
NPI: 1134238496Primary Practice Location
FORREST GENERAL HOSPITAL
6051 US 49, Hattiesburg, MS
Primary Employer
Hattiesburg Clinic PA
hattiesburgclinic.com
HQ Phone
Get MD John's Phone NumberMobile
Get MD John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 760 | 2,112 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 751 | 2,480 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 460 | 563 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 290 | 1,039 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 153 | 1,138 |
Authors: Alberto Bessudo, Stephen Lim, Jacob Bitran, Shahrooz Eshaghian, James Berenson, Mehdi Moezi
Journal: Exp Hematol
Publication Date: 2022-04-10
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification.
Authors: Chainarong Limvarapuss, Naiyer Rizvi
Publication Date: 2018-03-16
Oxaliplatin as a radiosensitizing agent in rectal cancer.
Authors: Sergio Huerta
Journal: Anticancer Drugs
Lead Sponsor: Sermonix Pharmaceuticals Inc.
Collaborators: Linical Accelovance Group
Intervention / Treatment: DRUG: Fulvestrant, DRUG: Lasofoxifene
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
Lead Sponsor: BeyondSpring Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Docetaxel + Plinabulin (DP), DRUG: Docetaxel (D)